Literature DB >> 35614898

Continuing Progress in the Interdisciplinary Management of Peritoneal Metastases.

Beate Rau1, Olivier Glehen2, Paul H Sugarbaker3, M Haroon A Choudry4,5, Yukata Yonemura6,7, David L Morris8, Sebastian Stintzing9, David P Ryan10,11.   

Abstract

Entities:  

Year:  2022        PMID： 35614898      PMCID： PMC9082187          DOI： 10.1159/000523760

Source DB:  PubMed          Journal:  Visc Med        ISSN： 2297-4725


× No keyword cloud information.
  5 in total

Review 1.  Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications.

Authors:  Mohammad Alyami; Martin Hübner; Fabian Grass; Naoual Bakrin; Laurent Villeneuve; Nathalie Laplace; Guillaume Passot; Olivier Glehen; Vahan Kepenekian
Journal:  Lancet Oncol       Date:  2019-07       Impact factor: 41.316

2.  Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: A multi-institutional cohort from PSOGI.

Authors:  Andreas Brandl; Yutaka Yonemura; Olivier Glehen; Paul Sugarbaker; Beate Rau
Journal:  Eur J Surg Oncol       Date:  2020-10-14       Impact factor: 4.424

3.  Thermal dose determination in cancer therapy.

Authors:  S A Sapareto; W C Dewey
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-06       Impact factor: 7.038

4.  A Temperature of 40 °C Appears to be a Critical Threshold for Potentiating Cytotoxic Chemotherapy In Vitro and in Peritoneal Carcinomatosis Patients Undergoing HIPEC.

Authors:  Lea Schaaf; Heiko van der Kuip; Waltraud Zopf; Stefan Winter; Marina Münch; Thomas E Mürdter; Klaus-Peter Thon; Wolfgang Steurer; Walter E Aulitzky; Christoph Ulmer
Journal:  Ann Surg Oncol       Date:  2015-09-08       Impact factor: 5.344

5.  Effects of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Neoadjuvant Intraperitoneal/Systemic Chemotherapy on Peritoneal Metastases from Gastric Cancer.

Authors:  Yutaka Yonemura; Haruaki Ishibashi; Masamitu Hirano; Akiyoshi Mizumoto; Kazuyosi Takeshita; Kousuke Noguchi; Nobuyuki Takao; Masumi Ichinose; Yang Liu; Yan Li
Journal:  Ann Surg Oncol       Date:  2016-08-09       Impact factor: 5.344
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.